Hers Review

Hers: the women-focused face of a telehealth giant

Hers is the women's brand of Hims & Hers, one of the largest direct-to-consumer telehealth companies in the country. That lineage is really the whole story here. You are not signing up with a scrappy weight-loss startup that might vanish in a year; you are getting a polished, mainstream platform with a national footprint, a recognizable name, and the kind of slick onboarding most patients already expect from a consumer health app. For a lot of people, that brand reassurance is exactly what they want when they start a semaglutide program. The trade-off is that Hers is built for the mass market, not for someone who wants to interrogate the fine print before they commit.

How the pricing actually works (and why one number isn't the whole picture)

On paper, Hers lists medication starting at $149 a month, which sits a bit above our category median of $169. But the headline price is not the full cost, and this is the single most important thing to understand before you sign up. The advertised figure covers medication only, if you are prescribed it. Underneath that sits a separate Hers Weight Loss Membership that is billed on its own: a low introductory rate for the first month that then auto-renews at a much higher monthly fee — a mid-three-figure rate that you keep paying for as long as you stay on the program.

In other words, the real monthly outlay is the medication line plus the membership line, and the membership is where the consult and the ongoing clinical support live. Hers does not bundle the visit or coaching into the medication price the way some competitors do — our record shows medication included, but consult and coaching are not. Budget for both charges, and watch that first-month teaser membership rate, because the renewal is several times higher.

• Medication line: $149/month starting price, medication only
• Membership line: billed separately — a low first-month rate, then a much higher recurring monthly fee
• Not included in the headline number: the provider visit and ongoing coaching sit inside the membership, not the medication price

What you're actually getting in the bottle

Our verified record lists Hers as a compounded semaglutide program. Compounded semaglutide is the same active ingredient found in the brand-name GLP-1 injections, made by a compounding pharmacy rather than the original manufacturer. That is how Hers can offer a lower entry price than brand-name pens. One important caveat: the broader Hims & Hers lineup has been shifting toward brand-name options and a wider menu, so what you are quoted at intake may differ from the compounded row we have on file. Confirm the exact formulation, dose, and delivery format on the checkout screen before you pay — do not assume the marketing page matches what lands in your cart.

Truly nationwide reach — with an asterisk

Hims & Hers operates in all 50 states, and that scale is a genuine advantage. The platform itself is not accessible in Puerto Rico, and more importantly, the company is explicit that specific treatments can be limited to certain states even when the overall brand is available everywhere. So the weight-loss program may not be live in your state even though Hers as a brand technically is. The fix is simple: run your state and ZIP through the intake flow before you get attached to the price. This is the same nationwide-reach-with-fine-print pattern you will see across big telehealth brands, and it is worth checking against our scoring methodology for how we weigh access.

What sets Hers apart

The real differentiator is not the medication or the price — it is the consumer experience and the trust that comes with a household name. Hers nails the parts that intimidate first-time GLP-1 patients: a clean app, a familiar brand, a membership that wraps the clinical relationship into one tidy subscription, and the comfort of going with a company that is publicly traded and not going anywhere. If you have been putting off starting because the whole category feels sketchy or hard to navigate, Hers lowers that barrier better than almost anyone.

What it does not offer is transparency for the detail-oriented shopper. Our record flags limited public information on program details, and that matches what we found: the pharmacy partners, the specifics of clinical oversight, and the full program terms are not laid out the way the most disclosure-forward providers do it. You are trusting the brand rather than auditing the operation.

Who should choose Hers — and who should skip it

Choose Hers if you want mainstream, low-friction GLP-1 access from a name you already recognize, you value a smooth app experience over granular control, and you are comfortable paying a separate membership for the clinical side. It is a sensible default for someone who just wants to get started without overthinking it.

Skip Hers if you are price-sensitive and want one all-in number, because the medication-plus-membership structure can add up once that first-month rate renews. Skip it too if you are the kind of patient who wants to see exactly which pharmacy compounds your medication, what the accreditation looks like, and every line of the program terms before you pay — Hers keeps more of that behind the curtain than the most transparent competitors.

Trust, safety, and medical oversight

On the safety ledger, the good news is clean: Hers has an FDA warning letter on file, covered in the regulatory notice below, though it operates as part of a large, scrutinized public company, which brings a level of corporate accountability smaller players lack. The honest gap is disclosure. We have no specific compounding-pharmacy partner or accreditation detail published for the weight-loss program, so our confidence rests more on the brand's scale than on line-by-line verification of the supply chain. If pharmacy accreditation is a dealbreaker for you, ask Hers directly before you start and get the answer in writing.

The bottom line

Hers is a strong pick for mainstream telehealth GLP-1 access: trusted brand, nationwide footprint, easy onboarding, and a compounded semaglutide entry point at $149 a month. Just go in clear-eyed about two things — the real cost is the medication plus a separate, auto-renewing membership, and the program details are thinner than what the most transparent providers publish. Confirm your state, confirm the exact formulation at checkout, and total up both charges before you commit. Do that, and Hers is a perfectly reasonable, low-stress way to begin.

Shopping around? Yucca Health ($146/month) and Gala ($149/month) are the nearest alternatives to Hers in our rankings.